Trial NCT02609048

View at ClinicalTrials.gov 
Org. Study IDs: CB8025-21528

Last trial update was posted on 2018-01-29

MeSH Interventions

Seladelpar

MeSH Conditions

Fibrosis Liver Cirrhosis Liver Cirrhosis, Biliary

Other Conditions

Primary Biliary Cirrhosis (PBC)

Stopping Reasons

Study stopped early after review of safety and efficacy demonstrated efficacy proof-of-concept and need for dose reduction.

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID